Fran Schulz - 09 Dec 2024 Form 4 Insider Report for Senti Biosciences, Inc. (SNTI)

Role
Director
Signature
/s/ Robert Cutler, attorney-in-fact
Issuer symbol
SNTI
Transactions as of
09 Dec 2024
Net transactions value
$0
Form type
4
Filing time
10 Dec 2024, 16:17:33 UTC
Next filing
11 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNTI Stock Option (Right to Buy) Award $0 +12,500 $0.000000 12,500 09 Dec 2024 Common Stock 12,500 $6.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest in 36 substantially equal monthly installments over three years from December 9, 2024, subject to the reporting person's continued service through the applicable vesting date.